Inventiva Sa (IVA) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN US46124U1079
Inventiva Sa financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 9.20 m EUR | 4.48 m EUR |
| Gross profit | 9.20 m EUR | 1.51 m EUR |
| Operating income | -97.56 m EUR | -130.95 m EUR |
| EBIT | -171.72 m EUR | -130.95 m EUR |
| Net income | -184.21 m EUR | -340.16 m EUR |
| Diluted EPS – continuing operations | -3.54 EUR | -1.82 EUR |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Inventiva Sa
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
More stocks
- Beijing Sojo Electric Co Ltd (300444.SZ)
- Jolywood Suzhou Sunwatt Co Ltd (300393.SZ)
- POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
- Chuzhou Duoli Automotive Technology Co. Ltd. A (001311.SZ)
- Caina Technology Co. Ltd. (301122.SZ)
- Alto Neuroscience, Inc. (ANRO)
- Rockpoint Gas Storage Inc (RGSI.TO)
- Changsha DIALINE New Material Sci & Tech Co Ltd (300700.SZ)
- Burford Capital Ltd (BUR)
- DAILY JOURNAL CORP (DJCO)
- Netac Tech (300042.SZ)
- 2G Energy (2GB.DE)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.